Showing results (31-40 of 70) with videos related to
Sort By:
Pageof 7
Healthcare (Basel, Switzerland)|June 12, 2026
Adoption and Efficiency of an Anesthesia Information Management System: Evaluation of Workflow Integration in Perioperative CareNikola Prpic, Ileana Lulic, Laura Karla Bozic, et al.The American Journal of Psychiatry|July 15, 2014
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptylineRudolf Uher, Katherine E Tansey, Tracy Dew, et al.The Journal of Clinical Psychiatry|December 1, 2011
Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) studyRudolf Uher, Ole Mors, Marcella Rietschel, et al.Croatian Medical Journal|November 6, 2018
Choline and N-acetyl aspartate levels in the dorsolateral prefrontal cortex at the beginning of the recovery phase as markers of increased risk for depressive episode recurrence under different duration of maintenance therapy and after it: a retrospective cohort studyNeven Henigsberg, Aleksandar Savić, Marko Radoš, et al.Frontiers in Psychiatry|January 12, 2018
Lower Choline-Containing Metabolites/Creatine (Cr) Rise and Failure to Sustain NAA/Cr Levels in the Dorsolateral Prefrontal Cortex Are Associated with Depressive Episode Recurrence under Maintenance Therapy: A Proton Magnetic Resonance Spectroscopy Retrospective Cohort StudyNeven Henigsberg, Helena Šarac, Marko Radoš, et al.Psychopharmacology|September 5, 2019
Choline elevation in amygdala region at recovery indicates longer survival without depressive episode: a magnetic resonance spectroscopy studyNeven Henigsberg, Aleksandar Savić, Marko Radoš, et al.Journal of Affective Disorders|March 18, 2011
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptylineRudolf Uher, Mojca Zvezdana Dernovsek, Ole Mors, et al.Brain, Behavior, and Immunity|March 5, 2017
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depressionOle Köhler-Forsberg, Henriette N Buttenschøn, Katherine E Tansey, et al.Journal of Psychiatric Research|April 19, 2016
Combining clinical variables to optimize prediction of antidepressant treatment outcomesRaquel Iniesta, Karim Malki, Wolfgang Maier, et al.The Journal of Clinical Psychiatry|July 19, 2019
Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive DisorderTrine Madsen, Henriette N Buttenschøn, Rudolf Uher, et al.Pageof 7